These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35770627)

  • 1. Losartan as therapy for recessive dystrophic epidermolysis bullosa: Report of three cases.
    Relvas M; Figueiredo AC; Calado R; Calvão J; Ramos L
    Dermatol Ther; 2022 Sep; 35(9):e15678. PubMed ID: 35770627
    [No Abstract]   [Full Text] [Related]  

  • 2. Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa.
    Inamadar AC
    Dermatol Ther; 2020 Nov; 33(6):e14279. PubMed ID: 32888385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified oral cannabidiol for pain management in severe recessive dystrophic epidermolysis bullosa.
    Welponer T; Diem A; Nahler G; Laimer M
    Indian J Dermatol Venereol Leprol; 2022; 88(4):551-552. PubMed ID: 35593277
    [No Abstract]   [Full Text] [Related]  

  • 4. Losartan treatment improves recessive dystrophic epidermolysis bullosa: A case series.
    Pourani MR; Vahidnezhad H; Mansouri P; Youssefian L; Rakhshan A; Hajimoradi B; Abdollahimajd F; Uitto J
    Dermatol Ther; 2022 Jul; 35(7):e15515. PubMed ID: 35420725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa.
    Oldakovskiy V; Murashkin N; Lokhmatov M; Gusev A; Tupylenko A; Budkina T; Yatzik S; Dyakonova E; Abaykhanov R; Fisenko A
    J Pediatr Surg; 2023 Apr; 58(4):619-623. PubMed ID: 36566169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of dystrophic epidermolysis bullosa pruriginosa symptoms with dupilumab: A case report.
    Wang Y; Zhou M; Zhang L; Zheng S; Hong Y; Gao XH
    Dermatol Ther; 2021 Nov; 34(6):e15130. PubMed ID: 34528352
    [No Abstract]   [Full Text] [Related]  

  • 7. Dominant dystrophic epidermolysis bullosa with congenital absence of skin and brachydactyly of the great toes.
    Sawka E; Funk T
    Pediatr Dermatol; 2021 Sep; 38(5):1251-1254. PubMed ID: 34338359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.
    Nyström A; Thriene K; Mittapalli V; Kern JS; Kiritsi D; Dengjel J; Bruckner-Tuderman L
    EMBO Mol Med; 2015 Sep; 7(9):1211-28. PubMed ID: 26194911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa pruriginosa: A rare entity which responded well to thalidomide.
    Rani S; Gupta A; Bhardwaj M
    Dermatol Ther; 2019 Sep; 32(5):e13035. PubMed ID: 31355515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
    [No Abstract]   [Full Text] [Related]  

  • 11. Case of intermediate recessive dystrophic epidermolysis bullosa with negative LH7.2 staining.
    Yoshida K; Kobayashi M; Matsunaga Y; Kubo A; Ishiko A
    J Dermatol; 2020 Oct; 47(10):e370-e372. PubMed ID: 32656782
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa.
    Hunjan MK; Bardhan A; Harper N; Langman G; Ajayi B; Suresh V; Heagerty AHM
    Clin Exp Dermatol; 2022 Aug; 47(8):1588-1590. PubMed ID: 35426452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
    Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient.
    Xará J; Relvas M; Figueiredo C; Calvão J; Batista M; Ramos L
    Int J Dermatol; 2023 Dec; 62(12):e617-e618. PubMed ID: 37622659
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcinosis cutis in self-healing dominant dystrophic epidermolysis bullosa.
    Takashima S; Fujita Y; Shinkuma S; Shimizu S; Hasegawa T; Amizuka N; Shimizu H; Natsuga K
    J Dermatol; 2020 Dec; 47(12):e457-e458. PubMed ID: 32885855
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful use of cyclosporine in epidermolysis bullosa pruriginosa.
    Kaushik A; Mahajan R; Karim A; Handa S; De D; Saikia B
    Dermatol Ther; 2020 Nov; 33(6):e14489. PubMed ID: 33131200
    [No Abstract]   [Full Text] [Related]  

  • 17. Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds?
    Annicchiarico G; Lopalco G; Morgese MG; Cantarini L; Iannone F
    Clin Exp Rheumatol; 2016; 34(5):961-962. PubMed ID: 26885873
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab.
    Caroppo F; Milan E; Giulioni E; Belloni Fortina A
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e365-e367. PubMed ID: 34927769
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
    Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
    J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.